ARCHIVES

In Brief: FDA Stops Imports Of Counterfeit Adriamychin; Rosenburg: NIH Pay 25-33% That Of Academia

This article is from The Cancer Letter archive.

Vol. 14 No. 17 | April 22, 1988

Download PDF Visit The Full Archive

Related Articles

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

September 30, 2005

Senate Committee Proposes $301 Million Increase For NIH

September 22, 1995

NCI Cooperative Group, Cancer Center Trials Listed

June 27, 2008

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

January 19, 2007

Study: HPV Testing Can Predict Precancers For Nearly Two Decades Following Exam

August 31, 2012

“Great Charlie Moertel Shootout: In Tucson Draws Laughs, Criticism

April 17, 1981